Welcome to our dedicated page for Bruker Corporation news (Ticker: BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker Corporation stock.
Bruker Corporation (symbol: BRKR) stands as a global leader in analytical instrumentation. With over fifty years of innovation, Bruker aims to provide top-tier technological solutions for various analytical tasks. Headquartered in Massachusetts, USA, Bruker employs more than 6,500 individuals across 90 locations worldwide.
The company's operations are categorized into four main segments:
- BSI BioSpin: Specializes in magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.
- BSI CALID: Focuses on mass spectrometry, chromatography, molecular spectroscopy, and in vitro diagnostics.
- BSI Nano: Offers solutions in X-ray diffraction, elemental analysis, atomic force microscopy, and surface and dimensional metrology.
- Bruker Energy & Supercon Technologies (BEST): Provides superconducting materials and devices for energy, science, and healthcare sectors.
Bruker demonstrates a strong commitment to research and development, continuously expanding its suite of products and maintaining a robust installed base globally. The company’s dedication to quality and reliability is reflected in its significant presence in the Asia Pacific region, which accounts for the largest share of its revenue.
Recent achievements include advancements in mass spectrometry and collaborations with leading pharmaceutical and biotechnology companies. Bruker's technologies are vital for quality assurance in industrial production processes, supporting customers in ensuring precision and reliability.
Bruker Corporation is not just a manufacturer but a partner in innovation, helping scientists and researchers address complex analytical challenges with integrity and cutting-edge technology.
Bruker Corporation (NASDAQ: BRKR) and Newomics Inc. announced a co-marketing collaboration focused on a novel LC-MS platform for drug discovery in pharma and biopharma. The partnership will integrate Newomics’ Microflow-nanospray Electrospray Ionization (MnESI) products with Bruker’s mass spectrometers, enhancing isotopic fidelity and sensitivity for biological sample analysis. Both companies highlight their successful R&D collaborations and the potential for improved results in biopharmaceutical and clinical research.
Bruker Corporation (Nasdaq: BRKR) will participate in Cowen’s 42nd Annual Health Care Conference from March 7-9, 2022. Gerald Herman, Executive VP & CFO, will present on March 7, 2022, at 2:50 PM EST. A live webcast of the presentation will be accessible on the Company’s Investor Relations website, with a replay available for 90 days post-event. Bruker specializes in high-performance scientific instruments and solutions that enhance life sciences and diagnostics, empowering scientific breakthroughs.
Bruker Corporation has announced an increase in its quarterly cash dividend to
Bruker Corporation (Nasdaq: BRKR) reported Q4 2021 revenues of $683.5 million, an increase of 8.9% year-over-year, with organic growth of 11.4%. FY 2021 revenues reached $2.42 billion, up 21.7%, with non-GAAP EPS rising 55.6% to $2.10. For FY 2022, Bruker expects revenue growth between 5% to 7%, and non-GAAP EPS guidance of $2.29 to $2.33, reflecting solid performance despite ongoing supply chain challenges. Significant investments in Project Accelerate 2.0 focus on proteomics and spatial biology are expected to drive future growth.
Bruker Corporation (Nasdaq: BRKR) will participate in the 11th Annual SVB Leerink Global Healthcare Conference virtually on February 16, 2022, at 8:40 AM EST. Frank Laukien, Chairman, President & CEO, will represent the company. Interested parties can access a live audio webcast on the Investor Relations section of Bruker's website. A replay will be available for 30 days post-event. Bruker specializes in high-performance scientific instruments and solutions for life sciences and diagnostics, contributing to advancements in molecular and cellular research.
Bruker Corporation (Nasdaq: BRKR) unveiled its innovative Sierra SPR-32 Pro at the SLAS2022 International Conference, enhancing high-throughput screening (HTS) capabilities. This advanced microfluidic system allows parallel readout of 32 sensor spots, significantly expediting drug development by reducing measurement time by up to threefold. The system is ideal for characterizing biologics and small molecules, supporting complex assays with high sensitivity. Bruker's integration with automation and data transfer to analysis software streamlines research processes for drug discovery.
Bruker Corporation (Nasdaq: BRKR) has launched the timsTOF MALDI PharmaPulse®, a groundbreaking high-throughput screening system at the SLAS2022 International Conference. This innovative platform combines Trapped Ion Mobility Spectrometry and high-resolution mass spectrometry for unmatched assay specificity. With speeds of 10 kHz, it supports various HTS applications, promising to enhance drug discovery by reducing false discovery rates. The software integration allows seamless data transfer for efficient analysis and demonstrates significant advancements in drug molecule design.
Bruker Corporation (NASDAQ: BRKR) announced its acquisition of Danish company PepSep, enhancing its nanoLC offerings. This acquisition aims to optimize nanoflow proteomics workflows, particularly for Bruker’s nanoElute® UHPLC system. Additionally, Bruker established an OEM agreement with IonOpticks to produce high-performance nanoLC Aurora columns. Both PepSep and IonOpticks solutions are designed to improve the performance and ease of use of the timsTOF 4D-Proteomics solutions, which is essential for high-throughput proteomics applications.
Bruker Corporation (Nasdaq: BRKR) will report its fourth quarter and fiscal year 2021 financial results on February 11, 2022, before market opening. A conference call and webcast will follow at 8:30 a.m. EST. Investors can access the call via Bruker’s investor relations website, and a telephone replay will be available until March 11, 2022. The company specializes in high-performance scientific instruments, enabling research across various life science and industrial applications.
FAQ
What is the current stock price of Bruker Corporation (BRKR)?
What is the market cap of Bruker Corporation (BRKR)?
What does Bruker Corporation specialize in?
How is Bruker Corporation structured?
Where does Bruker generate most of its revenue?
How many employees does Bruker Corporation have?
What industries does Bruker serve?
What recent advancements has Bruker made?
What is BSI BioSpin known for?
Why are Bruker's technologies important in industrial production?
What is the BEST segment of Bruker Corporation?